Halle Ronk - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Halle Ronk

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Cancer Biology & Medicine|November 7, 2022

Targeting PP2A for cancer therapeutic modulationHalle Ronk, Jared S Rosenblum, Timothy Kung, et al.

Journal of Neurosurgery. Case Lessons|December 27, 2022

Acute worsening of CADASIL in a patient with COVID-19 infection: illustrative caseJared S Rosenblum, Jessa M Tunacao, Matthew A Nazari, et al.

Neuro-Oncology|October 17, 2021

Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma modelsAnne Marie Barrette, Halle Ronk, Tanvi Joshi, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Cancer Biology & Medicine|November 7, 2022

Targeting PP2A for cancer therapeutic modulationHalle Ronk, Jared S Rosenblum, Timothy Kung, et al.

Journal of Neurosurgery. Case Lessons|December 27, 2022

Acute worsening of CADASIL in a patient with COVID-19 infection: illustrative caseJared S Rosenblum, Jessa M Tunacao, Matthew A Nazari, et al.

Neuro-Oncology|October 17, 2021

Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma modelsAnne Marie Barrette, Halle Ronk, Tanvi Joshi, et al.

Pageof 1